Literature DB >> 34071457

Physical Exercise-Induced Myokines in Neurodegenerative Diseases.

Banseok Lee1, Myeongcheol Shin1, Youngjae Park1, So-Yoon Won1,2, Kyoung Sang Cho1,2.   

Abstract

Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS), are disorders characterized by progressive degeneration of the nervous system. Currently, there is no disease-modifying treatments for most NDs. Meanwhile, numerous studies conducted on human and animal models over the past decades have showed that exercises had beneficial effects on NDs. Inter-tissue communication by myokine, a peptide produced and secreted by skeletal muscles during exercise, is thought to be an important underlying mechanism for the advantages. Here, we reviewed studies about the effects of myokines regulated by exercise on NDs and their mechanisms. Myokines could exert beneficial effects on NDs through a variety of regulatory mechanisms, including cell survival, neurogenesis, neuroinflammation, proteostasis, oxidative stress, and protein modification. Studies on exercise-induced myokines are expected to provide a novel strategy for treating NDs, for which there are no adequate treatments nowadays. To date, only a few myokines have been investigated for their effects on NDs and studies on mechanisms involved in them are in their infancy. Therefore, future studies are needed to discover more myokines and test their effects on NDs.

Entities:  

Keywords:  Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; exercise; muscle–brain axis; myokines; neurodegenerative diseases

Year:  2021        PMID: 34071457     DOI: 10.3390/ijms22115795

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  333 in total

1.  A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues.

Authors:  Suleyman Aydin; Tuncay Kuloglu; Suna Aydin; Mehmet Kalayci; Musa Yilmaz; Tolga Cakmak; Serdal Albayrak; Sami Gungor; Neriman Colakoglu; Ibrahim Hanifi Ozercan
Journal:  Peptides       Date:  2014-09-27       Impact factor: 3.750

Review 2.  Pathology of Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-07-05       Impact factor: 10.005

3.  Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury.

Authors:  Lauren A O'Donnell; Arpita Agrawal; Praveena Sabnekar; Marc A Dichter; David R Lynch; Dennis L Kolson
Journal:  J Neurochem       Date:  2007-09       Impact factor: 5.372

4.  Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

Authors:  D M Frim; T A Uhler; W R Galpern; M F Beal; X O Breakefield; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

5.  Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury.

Authors:  S D Skaper; A Negro; L Facci; R Dal Toso
Journal:  J Neurosci Res       Date:  1993-03-01       Impact factor: 4.164

6.  Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines.

Authors:  Hyun-Seuk Moon; Fadime Dincer; Christos S Mantzoros
Journal:  Metabolism       Date:  2013-05-07       Impact factor: 8.694

7.  FGF21 Protects the Blood-Brain Barrier by Upregulating PPARγ via FGFR1/β-klotho after Traumatic Brain Injury.

Authors:  Jun Chen; Jian Hu; Huan Liu; Ye Xiong; Yuchi Zou; Wenting Huang; Mingjie Shao; Jiamin Wu; Li Yu; Xiaojie Wang; Xue Wang; Li Lin
Journal:  J Neurotrauma       Date:  2018-06-29       Impact factor: 5.269

8.  Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

Authors:  G Schilling; M W Becher; A H Sharp; H A Jinnah; K Duan; J A Kotzuk; H H Slunt; T Ratovitski; J K Cooper; N A Jenkins; N G Copeland; D L Price; C A Ross; D R Borchelt
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

9.  Exercise increases serum fibroblast growth factor 21 (FGF21) levels.

Authors:  Daniel Cuevas-Ramos; Paloma Almeda-Valdés; Clara Elena Meza-Arana; Griselda Brito-Córdova; Francisco J Gómez-Pérez; Roopa Mehta; Jorge Oseguera-Moguel; Carlos A Aguilar-Salinas
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Neurodegenerative disease: models, mechanisms, and a new hope.

Authors:  Aaron D Gitler; Paraminder Dhillon; James Shorter
Journal:  Dis Model Mech       Date:  2017-05-01       Impact factor: 5.758

View more
  4 in total

Review 1.  Aerobic Physical Exercise as a Non-medical Intervention for Brain Dysfunction: State of the Art and Beyond.

Authors:  Yuxiang Jia; Yu Yao; Limin Zhuo; Xingxing Chen; Cuina Yan; Yonghua Ji; Jie Tao; Yudan Zhu
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

Review 2.  Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington's Disease.

Authors:  Bruno Trovato; Benedetta Magrì; Alessandro Castorina; Grazia Maugeri; Velia D'Agata; Giuseppe Musumeci
Journal:  J Funct Morphol Kinesiol       Date:  2022-05-11

3.  Effects of Leisure-Time Physical Activity on Cognitive Reserve Biomarkers and Leisure Motivation in the Pre-Diabetes Elderly.

Authors:  Bo-Ram Kim; Seung-Taek Lim
Journal:  Healthcare (Basel)       Date:  2022-04-15

Review 4.  Exercise-induced modulation of myokine irisin in bone and cartilage tissue-Positive effects on osteoarthritis: A narrative review.

Authors:  Ke Ning; Zhuo Wang; Xin-An Zhang
Journal:  Front Aging Neurosci       Date:  2022-08-19       Impact factor: 5.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.